TardiMed Sciences LLC - May 28, 2021 Form 4 Insider Report for Timber Pharmaceuticals, Inc. (TMBR)

Role
10%+ Owner
Signature
/s/ Michael Derby, Managing Partner of TardiMed Sciences LLC
Stock symbol
TMBR
Transactions as of
May 28, 2021
Transactions value $
-$84,019
Form type
4
Date filed
6/2/2021, 05:57 PM
Next filing
Jun 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMBR Common Stock, par value $0.001 per share Sale -$60.6K -47.7K -0.88% $1.27 5.39M May 28, 2021 Direct F1
transaction TMBR Common Stock, par value $0.001 per share Sale -$11K -8.67K -0.16% $1.26 5.38M Jun 1, 2021 Direct F2
transaction TMBR Common Stock, par value $0.001 per share Sale -$12.4K -9.88K -0.18% $1.26 5.37M Jun 2, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.32, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F2 The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.28, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.